NeoGenomics Analyst Price Targets

NeoGenomics Inc

NEONASDAQ

$17.38

-0.08-0.46%

al cierre: Sep 3, 5:00 PM EST

$17.23

-0.23-1.34%

Premercado: 5:44 AM EST

Wall Street analyst price targets and consensus rating for NeoGenomics (NEO).

Price Target Range — 11 Quarters

Analyst Consensus — 12 Analysts

10Buy

2Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$16Upside to Avg. PT-5.3%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 29, 2026	Needham	Mike Matson	PT Raise	Buy	$15→$19
Jul 24, 2026	Benchmark	Bruce D. Jackson	PT Raise	Buy	$11→$16
Apr 29, 2026	Benchmark	Bruce Jackson	Upgrade	Hold→Buy	$11
Apr 29, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$13→$14
Apr 29, 2026	Leerink Partners	Puneet Souda	Upgrade	Market Perform→Outperform	$12→$25
Feb 24, 2026	Piper Sandler	David Westenberg	PT Raise	Overweight	$12→$13
Feb 17, 2026	Needham	Mike Matson	PT Raise	Buy	$14→$15
Jan 12, 2026	Needham	Mike Matson	Maintained	Buy	$14
Sep 12, 2025	TD Cowen	Dan Brennan	PT Raise	Buy	$10→$12
Sep 2, 2025	Stephens & Co.	Mason Carrico	PT Raise	Overweight	$7→$11
Aug 29, 2025	Needham	Mike Matson	PT Raise	Buy	$8→$14
Aug 4, 2025	Piper Sandler	David Westenberg	PT Cut	Overweight	$12→$11
Jul 30, 2025	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$10→$8
Jul 29, 2025	Needham	Mike Matson	PT Cut	Buy	$9→$8
Jul 29, 2025	William Blair	—	Downgrade	Outperform→Market Perform	—
May 6, 2025	Piper Sandler	David Westenberg	PT Cut	Overweight	$18→$12
May 1, 2025	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$17→$10
Apr 30, 2025	Goldman Sachs	Matthew Sykes	PT Cut	Buy	$15→$10
Apr 30, 2025	Leerink Partners	Puneet Souda	Downgrade	Outperform→Market Perform	$25→$9
Apr 29, 2025	Needham	Mike Matson	PT Cut	Buy	$18→$9